TD Cowen Forecasts Strong Price Appreciation for agilon health (NYSE:AGL) Stock

agilon health (NYSE:AGL - Free Report) had its price objective boosted by TD Cowen from $3.50 to $6.00 in a research note issued to investors on Tuesday,Benzinga reports. TD Cowen currently has a hold rating on the stock.

Several other equities research analysts have also issued reports on the company. Macquarie began coverage on agilon health in a report on Monday, December 16th. They set a "neutral" rating and a $3.00 price target for the company. Sanford C. Bernstein upgraded shares of agilon health from a "market perform" rating to an "outperform" rating and lifted their target price for the company from $3.30 to $8.50 in a research note on Tuesday, April 8th. Robert W. Baird dropped their price target on shares of agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a research note on Tuesday. Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Finally, Stifel Nicolaus upped their price objective on shares of agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th. Two equities research analysts have rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $4.60.

agilon health Stock Down 26.4 %

Shares of NYSE:AGL traded down $1.45 during midday trading on Tuesday, hitting $4.02. 22,402,423 shares of the stock were exchanged, compared to its average volume of 4,792,850. The business's fifty day simple moving average is $4.14 and its two-hundred day simple moving average is $3.12. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a 52-week low of $1.50 and a 52-week high of $7.73. The company has a market capitalization of $1.66 billion, a PE ratio of -4.28 and a beta of 0.38.

Institutional Investors Weigh In On agilon health

Several large investors have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its holdings in shares of agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after purchasing an additional 1,083,492 shares in the last quarter. Inspire Investing LLC increased its position in shares of agilon health by 106.6% during the fourth quarter. Inspire Investing LLC now owns 217,550 shares of the company's stock worth $413,000 after acquiring an additional 112,241 shares in the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of agilon health during the fourth quarter worth $111,000. Raymond James Financial Inc. bought a new stake in agilon health in the 4th quarter valued at $33,000. Finally, Vanguard Group Inc. boosted its position in shares of agilon health by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after buying an additional 272,787 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.